Interleukin 6 and Tumor Necrosis Factor Alpha As Biomarkers of Jnk Inhibition
Biomarkers for JNK inhibition are described that can be used for monitoring effectiveness of JNK inhibitors and monitoring treatment with JNK inhibitors.
Attached files:Patents:WO 2,010,065,850
Inventor(s):
DAVIS ROGER J [US]; BUZO GUADALUPE SABIO [ES]; DAS MADHUMITA [US]
Type of Offer:
Sale
« More Biotech Patents